Диссертация (1174349), страница 26
Текст из файла (страница 26)
von Dadelszen // J. Obstet Gynaecol Can. - 2011. - Vol.33(5). – Р.516–529 [doi: 10.1016/S1701-2163(16)34886-1.PMID:21639972].180.Mahendroo, M. Cervical remodeling in term and preterm birth: insightsfrom an animal model / М. Mahendroo // Reproduction. - 2012. - Vol. 143 (4). –Р. 429 – 438.181.Malloy, M. Impact of cesarean section on neonatal mortality rates amongvery preterm infants in the United States, 2000–2003 / М. Malloy// Pediatrics. 2008. - Vol.
22(2). – Р. 285 – 292.182.Martinez de Tejada, B. Prevention of preterm delivery with vaginalprogesterone in women with preterm labour (4P): a randomised double-blind157placebo-controlled trial / В. Martinez de Tejada, А. Karolinski, М. Ocampo etal.// BJOG.
- 2015. - Vol. 122(1). – Р.80 – 91.183.Matijevic, R. Is sonographic assessment of cervical length better thandigital examination in screening for preterm delivery in a low-risk population?/R. Matijevic, О. Grgic, О.Vasilj // Acta Obstet Gynecol. - 2006. - Vol. 85. –Р.1342 - 1347.184.McGregor, J.Salivary estriol as risk assessment for preterm labor: aprospective trial / J. McGregor, G. Jackson, G.
Lachelin, et al. // Am J. ObstetGynec. - 1995. - Vol. 173 (4). – Р. 1337 - 1342.185.Meis, P. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate / Р. Meis, М. Klebanoff, Е. Thom, М.Dombrowski et al. // N Engl J Med. - 2003. - Vol. 348 (24). – Р. 2379 – 2385.186.Mella, M.
Prediction of preterm birth: cervical sonography / М. Mella, V.Berghella // Sem Perinatol. - 2009. - Vol. 33. – Р. 317 – 24.187.Miller, E. Second-trimester cervical length screening among asymptomaticwomen: an evaluation of risk-based strategies / Е. Miller, А. Tita, W. Grobman //ObstetGynecol.-2015.-Vol.126(1).–Р.61–6[doi:10.1097/AOG.0000000000000864].188.Moore, T. Neurological and developmental outcome in extremely pretermchildren born in England in 1995 and 2006: the EPICure studies / Т. Moore, Е.М. Hennessy, J.
Myles et al. // BMJ. 2012. - № 345. - P. e7961.189.Mori, R. Zinc supplementation for improvement pregnancy and infantoutcome / R. Mori, Е. Ota, Р. Middleton, et al. // Cochrane Database Syst. Rev. 2012. - Iss.7 [CD000230.PMID: 25642969].190.Moriette, G. Very premature births: Dilemmas and management. Part 1.Outcome of inf ants born before 28 weeks of postmenstrual age, and definition ofa gray zone / G.
Moriette, S. Rameix, Е. Azria, et al. // Arch. Pediatr.- 2010. Vol. 17(5). – Р. 518 – 526.158191.Moore, T. Neurological and developmental outcome in extremely pretermchildren born in England in 1995 and 2006: the EPICure studies / Т. Moore, Е.Hennessy, J. Myles., et al. // BMJ. - 2012. - Vol. 345. - P. e7961.192.Mourali, M. Cervical incompetence: diagnosis, indications, and cerclageoutcome / M. Mourali, A.Gharsa, A. Fatnassi, N.Binous, N.
Ben Zineb // TunisMed. - 2012. - Vol.90 (4). – P. 300 – 5 [PMID; 22535344].193.Nardin, J. Combination of tocolytic agents for inhibiting preterm labour(Protocol) / J. Nardin, G. Carroli, Z. Alfirevic // Cochrane Database Syst.Rev. 2006. - Vol. 4.194.Ness, A. Preterm labor. In: Berghella V., ed. Preterm birth. Prevention andmanagement / А. Ness, Y. Blumenfeld, J. Sung // Willey – Blackwell. - 2010. Vol. 198. – Р. 216.195.Nicolaides, K. A randomized trial of a cervical pessary to prevent pretermsingleton birth / К.
Nicolaides, А. Syngelaki, L. Poon, et al. // N. Engl J Med. 2016. – Vol.374. – Р.1044 – 1052 [doi: 10.1056/NEJ Moa 1511014].196.Oncel, M. The association of a cervical length of <25 mm in high-riskpregnancies on neonatal morbidity and mortality in preterm infants / М. Oncel,S. Arayici, S. Celen, et al. // Arch. Gynecol. Obstet. - 2013. - Vol.
287(5). – Р.893 – 899.197.O'Sullivan, M. 17 alpha-hydroxyprogesterone caproate vehicle, castor oil,enhances the contractile effect of oxytocin in human myometrium in pregnancy /М. O'Sullivan, et al // Am J Obstet Gynecol. - 2010. - Vol. 202(5). – Р. 453. e1-4[doi: 10. 1016/j.ajog. 2010.03.023].198.Owen, J.
Transperineal versus endovaginalultrasonography examinationof the cervix in the midtrimester: a blinded comparison / J. Owen, С. Neely, А.Northen//Am J Obstet Gynecol. - 1999. - Vol. 181. – Р. 780 – 3.199.Owen, J. Vaginal Ultrasound Trial Consortium. Multicenter randomizedtrial of cerclage for preterm birth prevention in high-risk women with shortenedmid-trimester cervical length / J. Owen // Am J.
Obstet Gynecol. - 2008. - Vol.199. – Р. S3.159200.Papatsonis, D. Oxytocin receptor antagonists for inhibiting preterm labour /D. Papatsonis, V. Flenady, S. Cole, Н. Liley// Cochrane Database Syst Rev.2005. - Vol. 3 [CD004452].201.Paternoster, D. Cervical phIGFBP-1 in the evaluation of the risk of pretermdelivery /D. Paternoster, D. Muresan, А.Vitulo, et al // Acta Obstet GynecolScand. - 2007. - Vol. 86. – Р.151 – 155.202.Paternoster, D.
Phosphorylated insulin-like growth factor binding protein-1 in cervical secretions and sonographic cervical length in the prediction ofspontaneous preterm delivery / D. Paternoster, F. Riboni, А.Vitulo, et al. //Ultrasound Obstet Gynecol. - 2009. - Vol. 34. – Р. 437 – 40.203.Peltoniemi, O. Randomized trial of a single repeat dose of prenatalbetamethasone treatment in imminent preterm birth / О.
Peltoniemi, М. Kari, О.Tammela, et al. // Pediatrics. - 2007. - Vol. 119(2). – Р.290 - 298.204.Petraglia, F. Neuroendocrine mechanisms in pregnancy and parturition / F.Petraglia, А. Imperatore, J. Challis, et al. // J. Endocr Rev. - 2010. - Vol. 31(6). –Р.783 - 816.205.Phillipe, M. Cell-free Fetal DNA-A trigger for parturition / М. Phillipe // NEngl J Med.
- 2014. - № 370. – Р. 2534 – 2536.206.Pignotti, M. Perinatalcare at the threshold of viability: an internationalcomparison of practical guidelines for the treatment of extremely preterm birth/М. Pignotti, G. Donzelli // Pediatrics. - 2008. - Vol. 121(1). – Р.191 – 198.207.Pignotti, M. Extremely preterm births: end-of-lifedecisions in Europeancountries / М. Pignotti, R. Berni // Arch.
Dis. Child. Fetal Neonatal Ed. - 2010. Vol. 95(4). – Р. F273 – 276.208.Racicot, K. Viral infection of the pregnant cervix predisposes to ascendingbacterial infection / К. Racicot, I. Cardenas, V. Wunsche, Р. Aldo, et al. // J.Immunol. - 2013. - Vol. 191(2). – Р. 934 – 941.209.Rahkonen, L. Factors affecting decidual IGFBP-1 concentrations in thevagina and cervix in the first and mid-second trimester of pregnancy / L.160Rahkonen, L.
Unkilla-Kallio, Е. Rutanen, J. Paavonen J. // BJOG. - 2009. Vol.116. - P. 45 – 54.210.Rahkonen, L.Elevated concentrations of decidual insulin-like growthfactor binding protein-1 in cervical fluid in early and mid-pregnancy areassociated with an increased risk of spontaneous preterm delivery / L. Rahkonen,Е. Rutanen, М.
Nuutila, et al. // BJOG. - 2010. - Vol. 117. – Р. 701 – 10.211.Rahkonen,L.Prediction of Pre-term Delivery with PhosphorylatedInsulin-like Growth Factor-binding Protein-1 / L. Rahkonen,// EuropeanObstetrics & Gynecology. - 2011. - Vol. 6(2). – Р. 95 – 9.212.Ramsey, P.S. Biochemical predictors of preterm labor: fetal fibronectin andsalivary estriol / P.S Ramsey, W.W. Andrews // Clinics in Perinatology.
- 2003. Vol. 30: Issue 4.213.RCOG Green-top Guideline N 7, October 2010, Antenatal Corticosteroidsto reduce Neonatal Morbidity and Mortality.214.RCOGGreen-Guideline top N 1b, February 2011, Tocolysis for womenin preterm labour.215.Reiter, E. Digital examination and transvaginal scan-competing orcomplementary for predicting preterm birth/ E. Reiter, K.Nielsen, J.
Fedder //ActaObstetGynecol Scand. - 2012. - Vol. 91(4). - Р.428 – 38 [doi:10.1111/j.1600 – 0412.2011.01341.x].216.Review of efficacy & safety of nifedipine as tocolytic in late pregnancy foraddition to the 14th Expert Committee on the Selection and Use of EssentialMedicines, March 7 – 11, 2005.217.Riboni,F.Biochemicalmarkerspredictingpreterm delivery insymptomatic patients: phosphorylated insulin-like growth factor binding protein1 and fetal fibronectin / F.
Riboni, А. Vitlo, М. Dell'avanzo et al. // Arch.Gynecol Obstet. - 2011. – Vol. 284. - Is.6: 1325 -1329.218.Riboni, F. Combination of biochemical markers in predicting pre-termdelivery / F. Riboni, А.Vitulo, М. Plebani et al. // Arch Gynecol Obstet. - 2012. Vol. 285(1). – Р. 61 – 6 [Epub 2011 May 3].161219.Romero, R. An oxytocin receptorantagonist (atosiban) in the treatment ofpreterm labor: a randomized, double-blind, placebo-controlled trial with tocolyticrescue. Am.
J. Obstet. Gynecol / R. Romero, В. Sibai, L. Sanches-Ramos, et al. //2000. - Vol.182(5). – Р. 173 – 1183.220.Romero, R. Vaginal progesterone to reduce the rate of preterm birth andneonatal morbidity a solution at last / R. Romero // Womens Health (Lond.Engl.). - 2011. - Vol. 7(5).
– Р. 501 – 504.221.Romero, R. Vaginal progesterone in women with an asymptomaticsonographic short cervix in the mid trimester decreases preterm delivery andneonatal morbidity: a systematic review and meta-analysis of individual patientdata / R. Romero, К. Nicolaides, А. Conde-Agudelo, et al.// Am. J. Obstet.Gynecol. - 2012.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
